» Articles » PMID: 28472372

ProteinsPlus: a Web Portal for Structure Analysis of Macromolecules

Overview
Specialty Biochemistry
Date 2017 May 5
PMID 28472372
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

With currently more than 126 000 publicly available structures and an increasing growth rate, the Protein Data Bank constitutes a rich data source for structure-driven research in fields like drug discovery, crop science and biotechnology in general. Typical workflows in these areas involve manifold computational tools for the analysis and prediction of molecular functions. Here, we present the ProteinsPlus web server that offers a unified easy-to-use interface to a broad range of tools for the early phase of structure-based molecular modeling. This includes solutions for commonly required pre-processing tasks like structure quality assessment (EDIA), hydrogen placement (Protoss) and the search for alternative conformations (SIENA). Beyond that, it also addresses frequent problems as the generation of 2D-interaction diagrams (PoseView), protein-protein interface classification (HyPPI) as well as automatic pocket detection and druggablity assessment (DoGSiteScorer). The unified ProteinsPlus interface covering all featured approaches provides various facilities for intuitive input and result visualization, case-specific parameterization and download options for further processing. Moreover, its generalized workflow allows the user a quick familiarization with the different tools. ProteinsPlus also stores the calculated results temporarily for future request and thus facilitates convenient result communication and re-access. The server is freely available at http://proteins.plus.

Citing Articles

Identification of (L.) Merr as a Novel Potential Therapeutic Agent Against COVID-19 and Pharyngitis.

Chen Q, He H, Zhu Y, Li X, Fang J, Li Z Molecules. 2025; 30(5).

PMID: 40076279 PMC: 11901475. DOI: 10.3390/molecules30051055.


Anti-carcinogenic effects of arecaidine but-2-ynyl ester tosylate on breast cancer: proliferation inhibition and activation of apoptosis.

Yavuz M, Kahyaogullari B, Demircan T Mol Biol Rep. 2025; 52(1):278.

PMID: 40035899 DOI: 10.1007/s11033-025-10385-7.


Cannabinoids as Promising Inhibitors of HER2-Tyrosine Kinase: A Novel Strategy for Targeting HER2-Positive Ovarian Cancer.

Lamtha T, Jongkon N, Lertvanithphol T, Horprathum M, Seetaha S, Choowongkomon K ACS Omega. 2025; 10(6):6191-6200.

PMID: 39989803 PMC: 11840771. DOI: 10.1021/acsomega.4c11108.


Structural insights into TRPV2 modulation by probenecid.

Rocereta J, Sturhahn T, Pumroy R, Fricke T, Herzog C, Leffler A Nat Struct Mol Biol. 2025; .

PMID: 39972168 DOI: 10.1038/s41594-025-01494-9.


Repurposing FDA-Approved Drugs Against Potential Drug Targets Involved in Brain Inflammation Contributing to Alzheimer's Disease.

Sharo C, Zhang J, Zhai T, Bao J, Garcia-Epelboim A, Mamourian E Targets (Basel). 2025; 2(4):446-469.

PMID: 39897171 PMC: 11786951. DOI: 10.3390/targets2040025.


References
1.
Nooren I, Thornton J . Structural characterisation and functional significance of transient protein-protein interactions. J Mol Biol. 2003; 325(5):991-1018. DOI: 10.1016/s0022-2836(02)01281-0. View

2.
Scharer M, Grutter M, Capitani G . CRK: an evolutionary approach for distinguishing biologically relevant interfaces from crystal contacts. Proteins. 2010; 78(12):2707-13. DOI: 10.1002/prot.22787. View

3.
Schmidtke P, Barril X . Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. J Med Chem. 2010; 53(15):5858-67. DOI: 10.1021/jm100574m. View

4.
Montelione G, Nilges M, Bax A, Guntert P, Herrmann T, Richardson J . Recommendations of the wwPDB NMR Validation Task Force. Structure. 2013; 21(9):1563-70. PMC: 3884077. DOI: 10.1016/j.str.2013.07.021. View

5.
Clark A, Labute P . 2D depiction of protein-ligand complexes. J Chem Inf Model. 2007; 47(5):1933-44. DOI: 10.1021/ci7001473. View